These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2203309)

  • 1. Open trial of cefepime (BMY 28142) for infections in hospitalized patients.
    Oster S; Edelstein H; Cassano K; McCabe R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):954-7. PubMed ID: 2203309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dosage cefepime as treatment for serious bacterial infections.
    Giamarellou H
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():123-32. PubMed ID: 8150755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects.
    Gentry LO; Rodriguez-Gomez G
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2371-4. PubMed ID: 1804010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
    Mouton Y; Chidiac C; Humbert G; Leroy J; Veyssier P; Modai J; Bertrand A; Dellamonica P; Micoud M; Stahl JP
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():133-40. PubMed ID: 8150757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cefepime (BMY 28142) to treat respiratory infections.
    Clynes N; Scully BE; Neu HC
    Diagn Microbiol Infect Dis; 1989; 12(3):257-60. PubMed ID: 2791488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Screen P; Becker N; August R
    J Clin Pharmacol; 1988 Feb; 28(2):179-89. PubMed ID: 3360968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections.
    Sharifi R; Geckler R; Childs S
    Am J Med; 1996 Jun; 100(6A):76S-82S. PubMed ID: 8678101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia.
    Edelstein H; Chirurgi V; Oster S; Karp R; Cassano K; Aiken S; McCabe R
    J Antimicrob Chemother; 1991 Oct; 28(4):569-75. PubMed ID: 1761451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
    Holloway WJ; Palmer D
    Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime in severe infections: a Swiss multicentre study.
    Francioli P; Clément M; Geroulanos S; von Graevenitz A; Luthy R; Regamey C; Stalder H; Vogt M; Waldvogel FA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections.
    Badaró R; Molinar F; Seas C; Stamboulian D; Mendonça J; Massud J; Nascimento LO;
    Braz J Infect Dis; 2002 Oct; 6(5):206-18. PubMed ID: 12495602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.
    Hoepelman AI; Kieft H; Aoun M; Kosmidis J; Strand T; Verhoef J; Gillespie SH; Riddell J; Varghese G; Meunier F
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():175-86. PubMed ID: 8150761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
    Chapman TM; Perry CM
    Am J Respir Med; 2003; 2(1):75-107. PubMed ID: 14720024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
    Barckow D; Schwigon CD
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():187-93. PubMed ID: 8150762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with the fourth generation cephalosporins.
    Giamarellou H
    J Chemother; 1996 Feb; 8 Suppl 2():91-104. PubMed ID: 8738851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric use of cefepime in the treatment of lower respiratory tract infections in children.
    Bradley JS; Arrieta A
    Pediatr Infect Dis J; 2001 Mar; 20(3):343-9. PubMed ID: 11303848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future management of serious skin and skin-structure infections.
    Schwartz R; Das-Young LR; Ramirez-Ronda C; Frank E
    Am J Med; 1996 Jun; 100(6A):90S-95S. PubMed ID: 8678103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.